OCT6 Activators
OCT6 activators are compounds that indirectly influence the expression or activity of OCT6 through various intracellular signaling pathways and transcriptional mechanisms. Agents like Forskolin and IBMX work to elevate intracellular cAMP, thereby activating PKA and influencing transcription factors that can lead to increased OCT6 expression. PMA, through the activation of PKC, has the potential to alter transcriptional activity, which can subsequently affect OCT6 levels. Retinoic acid and estrogen receptor agonists, such as beta-estradiol, exert their effects via receptor-mediated signaling pathways, leading to altered transcription of OCT6.
On the epigenetic front, compounds like sodium butyrate relax chromatin structure or reduce methylation, respectively, promoting the transcription of a variety of genes including OCT6. In addition, PPARγ agonists like rosiglitazone act on specific promoter elements to modulate gene expression profiles. Lithium chloride's inhibition of GSK-3 within the Wnt signaling cascade and farnesol's impact on a multitude of signal transduction pathways represent additional mechanisms by which OCT6 expression can be upregulated. The use of db-cAMP mimics the effects of endogenous cAMP, providing a direct tool for activating PKA and influencing gene expression. Lastly, Zinc, an essential mineral, can modulate OCT6 expression by serving as a vital cofactor for the proper functioning of various transcription factors.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylyl cyclase to increase cAMP levels, which enhances the transcription of OCT6 via PKA activation and subsequent effects on transcription factors. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Inhibits phosphodiesterase, preventing cAMP degradation, which could lead to enhanced OCT6 transcription via elevated intracellular cAMP. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC, which may modulate OCT6 expression through PKC-mediated signaling pathways influencing transcription. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Acts on retinoic acid receptors to regulate gene expression, potentially affecting OCT6 transcription via receptor-mediated signaling. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Inhibits histone deacetylase leading to chromatin remodeling, which may enhance transcription of the OCT6 gene. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Activates estrogen receptors that may influence OCT6 expression through estrogen-responsive elements in the gene's promoter. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Agonist for PPARγ that can upregulate OCT6 through modulation of PPARγ-responsive elements within its promoter. | ||||||
Farnesol | 4602-84-0 | sc-204748 sc-204748A | 50 ml 100 ml | $281.00 $374.00 | 2 | |
Modulates signal transduction pathways, which could affect the expression of OCT6. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3, potentially upregulating OCT6 by modifying components of the Wnt signaling pathway that regulate gene transcription. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that activates PKA, leading to transcriptional modulation and potential upregulation of OCT6 expression. | ||||||